Search research articles
Contact Us
Filters
Showing results (111-120 of 255) with videos related to
Page
of 26
Sort By:
Schizophrenia Research
|
May 23, 2008
Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)
Richard S E Keefe, Philip D Harvey, Terry E Goldberg, et al.
Clinics (Sao Paulo, Brazil)
|
May 29, 2015
Validity and reliability of the Brazilian Portuguese version of the BACS (Brief Assessment of Cognition in Schizophrenia)
Geovany Eliberto Araújo, Camilo Brandão de Resende, Ana Cecília Alves Cardoso, et al.
Schizophrenia Research
|
September 22, 2009
The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial
David L Penn, Richard S E Keefe, Sonia M Davis, et al.
Schizophrenia Research. Cognition
|
September 16, 2022
Dispersion of cognitive performance test scores on the MATRICS Consensus Cognitive Battery: A different perspective
David J Williamson, Keith H Nuechterlein, Todd Tishler, et al.
Psychological Medicine
|
July 29, 2014
Refining the latent structure of neuropsychological performance in schizophrenia
M Lam, S L Collinson, G K Eng, et al.
Journal of Affective Disorders
|
July 12, 2014
The Brief Assessment of Cognition In Affective Disorders (BAC-A):performance of patients with bipolar depression and healthy controls
Richard S E Keefe, Kolleen H Fox, Vicki G Davis, et al.
The Journal of Clinical Psychiatry
|
September 7, 2010
Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study
John M Kane, Deepak C D'Souza, Ashwin A Patkar, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 20, 2015
Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia
Richard S E Keefe, Herbert A Meltzer, Nancy Dgetluck, et al.
Journal of Psychiatric Research
|
May 27, 2017
Establishing the Brief Assessment of Cognition - Short form
Max Lam, Mingyuan Wang, Wanping Huang, et al.
Biological Psychiatry
|
December 13, 2006
NCAM1 and neurocognition in schizophrenia
Patrick F Sullivan, Richard S E Keefe, Leslie A Lange, et al.
Page
of 26
Search research articles
Search
Showing results (111-120 of 255) with videos related to
Sort By:
Page
of 26
Schizophrenia Research
|
May 23, 2008
Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS)
Richard S E Keefe, Philip D Harvey, Terry E Goldberg, et al.
Clinics (Sao Paulo, Brazil)
|
May 29, 2015
Validity and reliability of the Brazilian Portuguese version of the BACS (Brief Assessment of Cognition in Schizophrenia)
Geovany Eliberto Araújo, Camilo Brandão de Resende, Ana Cecília Alves Cardoso, et al.
Schizophrenia Research
|
September 22, 2009
The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial
David L Penn, Richard S E Keefe, Sonia M Davis, et al.
Schizophrenia Research. Cognition
|
September 16, 2022
Dispersion of cognitive performance test scores on the MATRICS Consensus Cognitive Battery: A different perspective
David J Williamson, Keith H Nuechterlein, Todd Tishler, et al.
Psychological Medicine
|
July 29, 2014
Refining the latent structure of neuropsychological performance in schizophrenia
M Lam, S L Collinson, G K Eng, et al.
Journal of Affective Disorders
|
July 12, 2014
The Brief Assessment of Cognition In Affective Disorders (BAC-A):performance of patients with bipolar depression and healthy controls
Richard S E Keefe, Kolleen H Fox, Vicki G Davis, et al.
The Journal of Clinical Psychiatry
|
September 7, 2010
Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study
John M Kane, Deepak C D'Souza, Ashwin A Patkar, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 20, 2015
Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia
Richard S E Keefe, Herbert A Meltzer, Nancy Dgetluck, et al.
Journal of Psychiatric Research
|
May 27, 2017
Establishing the Brief Assessment of Cognition - Short form
Max Lam, Mingyuan Wang, Wanping Huang, et al.
Biological Psychiatry
|
December 13, 2006
NCAM1 and neurocognition in schizophrenia
Patrick F Sullivan, Richard S E Keefe, Leslie A Lange, et al.
Page
of 26